02/03/2026
๐งฌ Improving how we predict human antibody drug responses
Antibody therapies are central to cancer, autoimmune, and inflammatory care, but many still fail late in clinical trials due to immune effects not seen in early testing.
๐ฌ Read full article at: https://ow.ly/mUT850Y836s
A new platform developed by researchers at VIBโGhent University introduces a human immuneโaccurate antibody testing model, capturing Fcฮณ receptor biology and platelet activation unique to humans. This approach helps identify safety risks, rank antibody candidates, and assess real-world immune responses earlier in development.
For clinicians, researchers, and nurses involved in translational research, this work highlights why preclinical accuracy matters for patient safety and treatment reliability.
Credit: VIB
New humanized platform improves prediction of Human Antibody Drug responses, reducing safety risks and late-stage failures.